No business has been able to effectively show a working variation of this technology, at least not to a business requirement. Reports appeared in 2017 that the company had a dedicated laboratory looking at ways to keep an eye on blood sugar through a wearable. Of course, this being an all-virtual CES, its even more difficult to take the companys fantastic claims at face value.
No company has actually been able to effectively demonstrate a working variation of this innovation, at least not to a business requirement. Rumors emerged in 2017 that the business had a devoted laboratory looking at ways to keep track of blood sugar through a wearable. It raised $60 million in investment from companies like GE, but failed to create a working product before it closed in early 2013. Of course, this being an all-virtual CES, its even harder to take the businesss fantastic claims at face worth.